![Ian Crosbie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian Crosbie
Amministratore Delegato presso SEQUANA MEDICAL N.V.
Profilo
Ian Crosbie is currently the Chief Executive Officer at Sequana Medical AG.
He is also the Chief Executive Officer & Executive Director at Sequana Medical NV, starting in 2019.
Additionally, he holds the position of Chief Financial Officer at Global Consolidated Aesthetics Ltd., starting in 2015.
In his former roles, Mr. Crosbie served as the Director of Healthcare Investment Banking at Deutsche Bank SA. He was also the Managing Director of Healthcare Investment Banking at Jefferies International Ltd.
Prior to that, he was a Founding Partner at Gargoyle Partners.
From 2013 to 2014, he held the position of Senior Vice President of Corporate Development at Niox Group Plc.
From 2015 to 2016, he served as the Chief Financial Officer at GC Aesthetics Plc.
Mr. Crosbie completed his graduate degree at the University of Oxford.
Posizioni attive di Ian Crosbie
Società | Posizione | Inizio |
---|---|---|
SEQUANA MEDICAL N.V. | Amministratore Delegato | 01/01/2016 |
Global Consolidated Aesthetics Ltd.
![]() Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | Direttore Finanziario/CFO | 01/01/2015 |
Sequana Medical AG
![]() Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Amministratore Delegato | - |
Precedenti posizioni note di Ian Crosbie
Società | Posizione | Fine |
---|---|---|
GC Aesthetics Plc
![]() GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland. | Direttore Finanziario/CFO | 01/06/2016 |
NIOX GROUP PLC | Corporate Officer/Principal | 01/12/2014 |
Deutsche Bank SA/NV
![]() Deutsche Bank SA/NV Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank SA/NV is a commercial bank based in Brussels, Belgium. | Corporate Officer/Principal | - |
Jefferies International Ltd.
![]() Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Corporate Officer/Principal | - |
Gargoyle Partners
![]() Gargoyle Partners Investment ManagersFinance Part of Ferghana Partners Group, Gargoyle Partners is a British company that provides healthcare and chemicals mergers and acquisition advisory. The company is based in London, UK. Gargoyle Partners was acquired by Ferghana Partners Group on October 11, 2005. | Corporate Officer/Principal | - |
Formazione di Ian Crosbie
University of Oxford | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NIOX GROUP PLC | Health Services |
SEQUANA MEDICAL N.V. | Health Technology |
Aziende private | 6 |
---|---|
Gargoyle Partners
![]() Gargoyle Partners Investment ManagersFinance Part of Ferghana Partners Group, Gargoyle Partners is a British company that provides healthcare and chemicals mergers and acquisition advisory. The company is based in London, UK. Gargoyle Partners was acquired by Ferghana Partners Group on October 11, 2005. | Finance |
GC Aesthetics Plc
![]() GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland. | Health Technology |
Global Consolidated Aesthetics Ltd.
![]() Global Consolidated Aesthetics Ltd. Medical SpecialtiesHealth Technology Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland. | Health Technology |
Sequana Medical AG
![]() Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
Jefferies International Ltd.
![]() Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Finance |
Deutsche Bank SA/NV
![]() Deutsche Bank SA/NV Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank SA/NV is a commercial bank based in Brussels, Belgium. | Finance |
- Borsa valori
- Insiders
- Ian Crosbie